Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

Stopped early · Not applicable

Conditions studied: Chronic Allograft Injury, Calcineurin Inhibitor Toxicity

In brief

The purpose of this study is to find out how well the current drug regimen (including low Prograf dose and Myfortic, which is usually recommended to prevent any further deterioration in the kidney function) works and how safe it is when compared to a combination of Zortress and Myfortic in patients with chronic kidney injury associated with Prograf or Neoral use.

Key facts

Study ID
NCT01473732
Run by
Montefiore Medical Center
People needed
2
Starts
2012-03-01
Expected to finish
2012-08-01
Last updated by the study team
2018-10-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.